Peter K Henke Selected Research

Venous Thrombosis (Deep-Vein Thrombosis)

1/2022	Modulation of interleukin-6 and its effect on late vein wall injury in a stasis mouse model of deep vein thrombosis.
1/2021	Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects.
1/2021	Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
1/2021	Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging Predicts Vein Wall Scarring and Statin Benefit in Murine Venous Thrombosis.
1/2020	Inflammatory biomarkers in deep venous thrombosis organization, resolution, and post-thrombotic syndrome.
7/2018	Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology.
4/2018	Evidence-Based Therapies for Pharmacologic Prevention and Treatment of Acute Deep Vein Thrombosis and Pulmonary Embolism.
1/2017	E-selectin inhibition with GMI-1271 decreases venous thrombosis without profoundly affecting tail vein bleeding in a mouse model.
1/2017	In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis.
1/2017	Endotoxaemia-augmented murine venous thrombosis is dependent on TLR-4 and ICAM-1, and potentiated by neutropenia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter K Henke Research Topics

Disease

55	Thrombosis (Thrombus) 01/2022 - 05/2002
48	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 11/2002
18	Abdominal Aortic Aneurysm 01/2021 - 02/2002
14	Fibrosis (Cirrhosis) 01/2022 - 11/2002
14	Inflammation (Inflammations) 01/2021 - 06/2003
13	Myocardial Infarction 01/2021 - 03/2003
12	Venous Thromboembolism 12/2022 - 09/2002
12	Aneurysm (Aneurysms) 04/2015 - 08/2004
11	Wounds and Injuries (Trauma) 01/2019 - 06/2005
9	Hemorrhage 01/2021 - 11/2005
8	Renal Insufficiency (Renal Failure) 01/2017 - 05/2002
8	Neoplasms (Cancer) 10/2012 - 05/2003
6	Pathologic Constriction (Stenosis) 02/2020 - 01/2006
6	Heart Failure 01/2020 - 02/2004
6	Stroke (Strokes) 01/2018 - 01/2004
5	Chronic Limb-Threatening Ischemia 11/2019 - 08/2013
5	Anemia 01/2018 - 12/2014
5	Peripheral Arterial Disease 01/2016 - 08/2011
4	Venous Insufficiency 01/2021 - 09/2005
4	Pneumonia (Pneumonitis) 01/2021 - 02/2007
4	Aortic Aneurysm (Aneurysm, Aortic) 01/2020 - 08/2004
4	Neutropenia 01/2017 - 05/2003
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2016 - 03/2003
4	Ischemia 03/2009 - 02/2002
3	Postthrombotic Syndrome 01/2021 - 02/2011
3	Pulmonary Embolism 01/2021 - 09/2002
3	Vascular Diseases (Vascular Disease) 01/2020 - 02/2004
3	Diabetes Mellitus 01/2020 - 05/2002
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 05/2002
3	Hypertension (High Blood Pressure) 01/2017 - 12/2006
3	Pain (Aches) 06/2010 - 05/2002
3	Aortic Dissection 10/2006 - 10/2002
2	Hyperplasia 01/2021 - 04/2006
2	COVID-19 01/2021 - 01/2021
2	Critical Illness (Critically Ill) 01/2021 - 01/2019
2	Cicatrix (Scar) 01/2021 - 01/2015
2	Leukemia 01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

18	P-SelectinIBA 01/2016 - 09/2002
16	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022 - 11/2002
14	Matrix Metalloproteinases (MMPs)IBA 11/2013 - 08/2004
13	CollagenIBA 01/2018 - 08/2003
10	Proteins (Proteins, Gene)FDA Link 03/2015 - 06/2003
8	AnticoagulantsIBA 01/2021 - 11/2002
8	CytokinesIBA 01/2019 - 09/2002
8	Pancreatic Elastase (Elastase)IBA 11/2016 - 08/2004
8	EnzymesIBA 09/2006 - 11/2002
6	fibrin fragment D (D-dimer)IBA 01/2021 - 12/2005
6	Histones (Histone)IBA 01/2020 - 04/2015
6	Plasminogen Activators (Plasminogen Activator)IBA 01/2015 - 10/2007
6	ImmunosorbentsIBA 09/2006 - 11/2002
5	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 09/2003
5	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018 - 06/2003
5	Plasminogen Activator Inhibitor 1IBA 10/2014 - 12/2010
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 02/2004
4	Toll-Like Receptor 9IBA 03/2020 - 01/2011
4	InterleukinsIBA 01/2018 - 08/2005
4	CreatinineIBA 06/2017 - 01/2007
4	E-SelectinIBA 01/2017 - 09/2002
4	Enoxaparin (Lovenox)FDA LinkGeneric 01/2017 - 02/2010
4	Thromboplastin (Tissue Factor)IBA 01/2015 - 11/2002
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2012 - 10/2007
4	Fibrinolysin FDA Link 10/2012 - 10/2007
4	ChemokinesIBA 01/2009 - 09/2002
3	Phenobarbital (Luminal)FDA Link 01/2022 - 03/2008
3	Fibrinogen (Factor I)FDA Link 01/2021 - 03/2009
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 04/2006
3	Biological ProductsIBA 11/2020 - 09/2005
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2011
3	Lysine (L-Lysine)FDA Link 01/2020 - 01/2017
3	Histone MethyltransferasesIBA 01/2019 - 01/2017
3	InterferonsIBA 01/2019 - 12/2010
3	LigandsIBA 01/2017 - 08/2005
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2014 - 05/2013
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2013 - 07/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2010 - 10/2007
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2007 - 04/2006
3	2- (4- chlorobenzyl)- 3- hydroxy- 7,8,9,10- tetrahydrobenzo(H)quinoline- 4- carboxylic acidIBA 03/2007 - 08/2005
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2015
2	Peroxidase (Myeloperoxidase)IBA 01/2021 - 01/2015
2	histone H3 trimethyl Lys4IBA 01/2019 - 01/2017
2	FibrinIBA 01/2018 - 01/2015
2	ElastinIBA 01/2018 - 11/2006

Therapy/Procedure

28	Therapeutics 01/2022 - 05/2003
13	Ligation 01/2022 - 11/2002
13	Surgical Amputation (Amputations) 11/2019 - 05/2002
8	Vascular Surgical Procedures 01/2021 - 01/2004
6	Renal Dialysis (Hemodialysis) 01/2019 - 05/2002
6	Limb Salvage 12/2014 - 02/2004
4	Chemoprevention 12/2022 - 05/2014
4	Catheters 01/2021 - 02/2003
4	Endovascular Procedures 11/2019 - 01/2006
3	Carotid Endarterectomy 01/2021 - 02/2005
3	Endovascular Aneurysm Repair 01/2021 - 04/2015
3	Length of Stay 01/2021 - 01/2004
3	Blood Transfusion (Blood Transfusions) 01/2016 - 02/2007
3	Thrombolytic Therapy 01/2015 - 11/2002
3	Colectomy 10/2012 - 11/2005
2	Aftercare (After-Treatment) 01/2022 - 08/2003
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021 - 11/2005
2	Critical Care (Surgical Intensive Care) 01/2019 - 05/2014